Semaglutide Recall: Northwest Compounders Lot 01-27-2026@14S.5
Announced 2026-04-22 · FDA
The FDA recall concerns 91 vials of Semaglutide-Glycine-Cyanocobalamin Injectable, Rx only, from Northwest Compounders in Beaverton, OR, due to lack of assurance of sterility. The recall is associated with Lot Number 01-27-2026@14S.5 and is limited to Oregon; no corrective action is provided in the notice.
| Brand | PAYLESS COMPOUNDERS, LLC |
|---|---|
| Product | Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg, 1 MG/ML, 0.5 mL vials, Rx only, Northwest Compounders, Beaverton, OR |
| Reason | Lack of Assurance of Sterility |
| Severity | moderate |
| Units affected | 91 |
| Distribution | OR |
| Agency | FDA |
WHAT YOU SHOULD DO
- Do not use any recalled vials.
- Check your inventory for Lot 01-27-2026@14S.5 and set aside any affected product.
- Contact your pharmacist or Northwest Compounders for disposal or replacement instructions and stop use until advised.
- If you have used this product and have health concerns, contact your healthcare provider immediately.
How to identify the recalled item
| Lot / date codes | Lot Number 01-27-2026@14S.5 |
|---|---|
| Lot / date codes | Lot Number 01-27-2026@14S.5 |
These are the identifiers FDA published for this recall. Most recall notices list no UPC or model number at all — if the code on your item is not shown here, that does not mean the item is excluded. Check the official notice, or contact the company.
Other semaglutide recalls
- Semaglutide Recall: Nomida Lot 241113 and Lot 250103 · 2026-03-11
- Semaglutide Recall: Harbin Jixianglong Biotech CP-030-20250711 · 2026-03-11
- Semaglutide Recall: Wegovy Injection Pens · 2026-01-07
- Semaglutide Recall: ProRx 2 mL Multidose Vial · 2025-11-05
- Semaglutide Recall: Boothwyn Pharmacy 2.5 mg/mL injection · 2025-09-10
This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.